Article Data

  • Views 1424
  • Dowloads 145

Original Research

Open Access

Breast cancer screening outcomes and risk assessment among women of Abha city, Saudi Arabia

  • Hayfa A. AlHefdhi1
  • Asma Saad Habbash1
  • Safar Abadi Al-Saleem1
  • Fatima Riaz1
  • Syed Esam Mahmood1,*,
  • Amal A. AlHefdhi2
  • Saad Abdullah Al Hatim3
  • Abdullah Ali Alqahtani3
  • Naif Shalan Alalyani3
  • Saeed Abdullah Alahmari3
  • Fahad Juwayid Alqahtani3
  • Rawan Hassan Alshehri3

1Department of Family and Community Medicine, College of Medicine, King Khalid University, 62529 Abha, Saudi Arabia

2Family Medicine Specialist, Diabetic Centre, Ministry of Health, 62523 Abha, Saudi Arabia

3General Practitioner, Ministry of Health, 62523 Abha, Saudi Arabia

DOI: 10.22514/ejgo.2024.001

Submitted: 02 October 2023 Accepted: 01 November 2023

Online publish date: 12 January 2024

*Corresponding Author(s): Syed Esam Mahmood E-mail:


Breast cancer is one of the most common cancers among women and the leadingcause of death related to cancers. This study focuses on the screening of breast cancer for earlydetection of breast cancer and identification of risk factors for the development of breast cancer. This cross-sectional study was conducted among the female participants who were registered for the breast cancer screening program conducted by King Khalid University, Abha under the supervision of Family and Community Medicine, Department of College of Medicine. Convenience sampling was done and a total of 331 patients were selected for the study. The collected data were coded and entered into an Excel software (Microsoft Office Excel 2010) database. Data was analyzed using Statistical Package for Social Sciences, version 16 (SPSS, Inc., Chicago, IL, USA). p < 0.05 was considered statistically significant. Out of 331 individuals only 3 (0.9%) were diagnosed with breast cancer. Three cases ofinvasive ductal carcinoma were identified among individuals with breast cancer. While 4 (1.2%) individuals had benign findings, such as fibroadenoma, ductal ectasia, sclerosing adenosis, andtissue fibrosis. Past surgical history, past radiotherapy/chemotherapy, and maternal problemsduring pregnancy were significantly associated with varying levels of breast cancer risk. Breastcomplaints show a significant association with breast cancer indicating the need for furtherinvestigation. Findings from physical examinations, mammography reports, breast ultrasound, biopsy referrals, biopsy results, and management plans all show significant relationships withbreast cancer risk. Our study findings indicate the need for health education for the prevention of breastcancer risk factors and the implementation of regular screening programs for the early detectionof the disease in the community.


Breast cancer; Screening; Risk factors; Outcomes

Cite and Share

Hayfa A. AlHefdhi,Asma Saad Habbash,Safar Abadi Al-Saleem,Fatima Riaz,Syed Esam Mahmood,Amal A. AlHefdhi,Saad Abdullah Al Hatim,Abdullah Ali Alqahtani,Naif Shalan Alalyani,Saeed Abdullah Alahmari,Fahad Juwayid Alqahtani,Rawan Hassan Alshehri. Breast cancer screening outcomes and risk assessment among women of Abha city, Saudi Arabia. European Journal of Gynaecological Oncology. 2024.doi:10.22514/ejgo.2024.001.


[1] Gao Y, Heller SL. Breast cancer screening in men. Journal of Breast Imaging. 2023; 5: 104–111.

[2] Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast cancer statistics, 2022. CA: A Cancer Journal for Clinicians. 2022; 72: 524–541.

[3] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2021; 71: 209–249.

[4] Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. The British Journal of Radiology. 2022; 95: 20211033.

[5] Zendehdel M, Niakan B, Keshtkar A, Rafiei E, Salamat F. Subtypes of benign breast disease as a risk factor for breast cancer: a systematic review and meta-analysis protocol. Iranian Journal of Medical Sciences. 2018; 43: 1–8.

[6] Chokoev A, Akhunbaev S, Kudaibergenova I, Soodonbekov E, Kulayev K, Ospanov K, et al. Breast cancer incidence in Kyrgyzstan: report of 15 years of cancer registry. Asian Pacific Journal of Cancer Prevention. 2022; 23: 1603–1610.

[7] Kim Y, Yoo K, Goodman MT. Differences in incidence, mortality and survival of breast cancer by regions and countries in Asia and contributing factors. Asian Pacific Journal of Cancer Prevention. 2015; 16: 2857–2870.

[8] Qi SA, Kumar N, Xu JY, Patel J, Damaraju S, Shen-Tu G, et al. Personalized breast cancer onset prediction from lifestyle and health history information. PLOS ONE. 2022; 17: e0279174.

[9] Thakur P, Seam RK, Gupta MK, Gupta M, Sharma M, Fotedar V. Breast cancer risk factor evaluation in a Western Himalayan state: a case-control study and comparison with the Western World. South Asian Journal of Cancer. 2017; 06: 106–109.

[10] Wang H, MacInnis RJ, Li S. Family history and breast cancer risk for Asian women: a systematic review and meta-analysis. BMC medicine. 2023; 21: 239.

[11] Laamiri FZ, Bouayad A, Hasswane N, Ahid S, Mrabet M, Amina B. Risk factors for breast cancer of different age groups: Moroccan data? Open Journal of Obstetrics and Gynecology. 2015; 5: 79–87.

[12] Zolfaroli I, Tarín JJ, Cano A. Hormonal contraceptives and breast cancer: Clinical data. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2018; 230: 212–216.

[13] Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet. 2019; 394: 1159–1168.

[14] Cobain EF, Milliron KJ, Merajver SD. Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. Seminars in Oncology. 2016; 43: 528–535.

[15] Melvin JC, Wulaningsih W, Hana Z, Purushotham AD, Pinder SE, Fentiman I, et al. Family history of breast cancer and its association with disease severity and mortality. Cancer Medicine. 2016; 5: 942–949.

[16] Byrne C, Ursin G, Martin CF, Peck JD, Cole EB, Zeng D, et al. Mammographic density change with estrogen and progestin therapy and breast cancer risk. JNCI: Journal of the National Cancer Institute. 2017; 109: djx001.

[17] Arthur R, Wang Y, Ye K, Glass AG, Ginsberg M, Loudig O, et al. Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease. Breast Cancer Research and Treatment. 2017; 165: 623–631.

[18] Miller ER, Wilson C, Chapman J, Flight I, Nguyen AM, Fletcher C, et al. Connecting the dots between breast cancer, obesity and alcohol consumption in middle-aged women: ecological and case control studies. BMC Public Health. 2018; 18: 460.

[19] Tong JH, Li Z, Shi J, Li HM, Wang Y, Fu LY, et al. Passive smoking exposure from partners as a risk factor for ER+/PR+ double positive breast cancer in never-smoking Chinese urban women: a hospital-based matched case control study. PLOS ONE. 2014; 9: e97498.

[20] Jordan I, Hebestreit A, Swai B, Krawinkel MB. Dietary patterns and breast cancer risk among women in northern Tanzania: a case-control study. European Journal of Nutrition. 2013; 52: 905–915.

[21] Park S, Lee DH, Jeon JY, Ryu J, Kim S, Kim JY, et al. Serum 25-hydroxyvitamin D deficiency and increased risk of breast cancer among Korean women: a case-control study. Breast Cancer Research and Treatment. 2015; 152: 147–154.

[22] Henderson TO, Moskowitz CS, Chou JF, Bradbury AR, Neglia JP, Dang CT, et al. Breast cancer risk in childhood cancer survivors without a history of chest radiotherapy: a report from the childhood cancer survivor study. Journal of Clinical Oncology. 2016; 34: 910–918.

[23] Saudi Cancer Registry. Cancer incidence report Saudi Arabia. Available at: (Accessed: 19 September 2023).

[24] Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, et al. Prediction of breast cancer risk based on profiling with common genetic variants. JNCI: Journal of the National Cancer Institute. 2015; 107: djv036.

[25] Morris E, Feig SA, Drexler M, Lehman C. Implications of overdiagnosis: impact on screening mammography practices. Population Health Management. 2015; 18: S3–S11.

[26] Cakir M, Kucukkartallar T, Tekin A, Selimoglu N, Poyraz N, Belviranli MM, et al. Comparison of mammography sensitivity after reduction mammoplasty targeting the glandular and fat tissue. Turkish Journal of Surgery. 2015; 31: 68–71.

[27] Pal UM, Saxena M, Anil Vishnu GK, Parsana D, Sarvani BSR, Varma M, et al. Optical spectroscopy-based imaging techniques for the diagnosis of breast cancer: a novel approach. Applied Spectroscopy Reviews. 2020; 55: 778–804.

[28] Mehnati P, Tirtash MJ. Comparative efficacy of four imaging instruments for breast cancer screening. Asian Pacific Journal of Cancer Prevention. 2015; 16: 6177–6186.

[29] Tan XJ, Cheor WL, Lim LL, Ab Rahman KS, Bakrin IH. Artificial intelligence (AI) in breast imaging: a scientometric umbrella review. Diagnostics. 2022; 12: 3111.

[30] Abulkhair OA, Al Tahan FM, Young SE, Musaad SM, Jazieh AM. The first national public breast cancer screening program in Saudi Arabia. Annals of Saudi Medicine. 2010; 30: 350–357.

[31] Al Mulhim FA, Syed A, Bagatadah WA, Al Muhanna AF. Breast cancer screening programme: experience from Eastern province, Saudi Arabia. Eastern Mediterranean Health Journal. 2015; 21: 111–119.

[32] Akhtar SS, Nadrah HM, Al Habdan MA, El Gabbani SA, El Farouk GM, Abdelgadir MH, et al. First organized screening mammography programme in Saudi Arabia: preliminary analysis of pilot round. Eastern Mediterranean Health Journal. 2010; 16: 1025–1031.

[33] Gosadi IM. National screening programs in Saudi Arabia: overview, outcomes, and effectiveness. Journal of Infection and Public Health. 2019; 12: 608–614.

[34] Cheema S, Maisonneuve P, Lowenfels AB, Abraham A, Doraiswamy S, Mamtani R. Influence of age on 2040 cancer burden in the older population of the gulf cooperation council (GCC) countries: public health implications. Cancer Control. 2021; 28: 10732748211027158.

[35] El Bcheraoui C, Basulaiman M, Wilson S, Daoud F, Tuffaha M, AlMazroa MA, et al. Breast cancer screening in Saudi Arabia: free but almost no takers. PLOS ONE. 2015; 10: e0119051.

[36] Topal F, Van Roosbroeck S, Van Hal G, Jacquemyn Y. Factors contributing to the low participation rate of Turkish women to a breast cancer screening program in Antwerp, Belgium. European Journal of Gynaecological Oncology. 2015; 392: 520–523.

[37] Basudan AM. Breast cancer incidence patterns in the Saudi female population: a 17-year retrospective analysis. Medicina. 2022; 58: 1617.

[38] Alqahtani WS, Almufareh NA, Domiaty DM, Albasher G, Alduwish MA, Alkhalaf H, et al. Epidemiology of cancer in Saudi Arabia thru 2010–2019: a systematic review with constrained meta-analysis. AIMS Public Health. 2020; 7: 679–696.

[39] Hoxha I, Sadiku F, Hoxha L, Nasim M, Christine Buteau MA, Grezda K, et al. Breast cancer and lifestyle factors. Hematology/Oncology Clinics of North America. 2024; 38: 137–170.

[40] Migliavacca Zucchetti B, Peccatori FA, Codacci-Pisanelli G. Pregnancy and lactation: risk or protective factors for breast cancer? Advances in Experimental Medicine and Biology. 2020; 43: 195–197.

[41] Sjöholm K, Carlsson LMS, Svensson P, Andersson-Assarsson JC, Kristensson F, Jacobson P, et al. Association of bariatric surgery with cancer incidence in patients with obesity and diabetes: long-term results from the Swedish obese subjects study. Diabetes Care. 2022; 45: 444–450.

[42] Kharazmi E, Sundquist K, Sundquist J, Fallah M, Bermejo JL. Risk of gynecological cancers in cholecystectomized women: a large nationwide cohort study. Cancers. 2022; 14: 1484.

[43] Kacimi SEO, Elgenidy A, Cheema HA, Ould Setti M, Khosla AA, Benmelouka AY, et al. Prior tonsillectomy and the risk of breast cancer in females: a systematic review and meta-analysis. Frontiers in Oncology. 2022; 12: 925596.

[44] Alsolami FJ, Azzeh FS, Ghafouri KJ, Ghaith MM, Almaimani RA, Almasmoum HA, et al. Determinants of breast cancer in Saudi women from Makkah region: a case-control study (breast cancer risk factors among Saudi women). BMC Public Health. 2019; 19: 1554.

[45] Babiker S, Nasir O, Alotaibi SH, Marzogi A, Bogari M, Alghamdi T. Prospective breast cancer risk factors prediction in Saudi women. Saudi Journal of Biologica. 2020; 27: 1624–467.

[46] Goldberg M, D’Aloisio AA, O’Brien KM, Zhao S, Sandler DP. Pubertal timing and breast cancer risk in the Sister Study cohort. 2020; 22: 112.

[47] Rahman S, Zayed H. Breast cancer in the GCC countries: a focus on BRCA1/2 and non-BRCA1/2 genes. Gene. 2018; 668: 73–76.

[48] Abulkhair O, Saadeddin A, Makram O, Gasmelseed A, Pasha T, Shehata H, et al. Vitamin D levels and breast cancer characteristics: findings in patients from Saudi Arabia. The Journal of Steroid Biochemistry and Molecular Biology. 2016; 164: 106–109.

[49] Voutsadakis IA. Vitamin D baseline levels at diagnosis of breast cancer: a systematic review and meta-analysis. Hematology/Oncology and Stem Cell Therapy. 2021; 14: 16–26.

[50] Ifediora CO. Re-thinking breast and cervical cancer preventive campaigns in developing countries: the case for interventions at high schools. BMC Public Health. 2019; 19: 503.

[51] Luna-Abanto J, Gamarra L, Armestar DD, Condori BH, Tisoc GBM, Trujillo GF, et al. Impact of cancer awareness campaigns in Peru: a 5-year Google trends analysis. ecancermedicalscience. 2022; 16: 1477.

[52] Aloufi AS, AlNaeem AN, Almousa AS, Hashem AM, Malik MA, Altahan FM, et al. Mammographic breast density and breast cancer risk in the Saudi population: a case-control study using visual and automated methods. The British Journal of Radiology. 2022; 95: 20211197.

[53] Hong Q, Guo Q, Wang W, Zhang Y, Wang Q, Lai Z. Study on female breast cancer imaging screening consultation network in Guangdong Province, China. European Journal of Gynaecological Oncology. 2016; 37: 189–193.

[54] Robbel C, Vesel L, Ernst E, He Y, Vesel T. Community member and health care provider perspectives on communication with Chinese American patients with cancer: a qualitative study. JCO Oncology Practice. 2022; 18: e1927–e1934.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time